Prolonged mechanical circulatory support with VA-ECMO for up to 21 days can provide the necessary hemodynamic stability for combined immunosuppression to effectively treat giant cell myocarditis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for prolonged VA-ECMO plus immunosuppression in giant cell myocarditis; leaves open need for prospective validation.
: A 31-year-old man presenting with cardiogenic shock and left ventricular ejection fraction of 10% received the diagnosis of giant cell myocarditis by endomyocardial biopsy. The patient was successfully treated with high-dose inotropes, intra-aortic balloon pump and venoarterial extracorporeal membrane oxygenation for 21 days associated with combined immunosuppression (thymoglobulin, steroids, cyclosporine). Immunosuppression including thymoglobulin is the regimen associated with the highest probability of recovery in case of giant cell myocarditis. Immunosuppression needs time to be effective; thus, hemodynamic support must be guaranteed. In the present case, we observed that full recovery can be obtained up to 21 days of support with extracorporeal membrane oxygenation and adequate immunosuppression.
No takes yet. Share an insight, caveat, or question.
Ammirati et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: